Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population

被引:16
作者
Oh, J. J. [1 ,2 ]
Byun, S-S [3 ]
Lee, S. E. [3 ]
Hong, S. K. [3 ]
Jeong, C. W. [3 ]
Choi, W. S. [4 ]
Kim, D. [5 ]
Kim, H. J. [6 ,7 ]
Myung, S. C. [6 ,7 ,8 ]
机构
[1] CHA Univ, Dept Urol, CHA Bundang Med Ctr, Songnam, South Korea
[2] CHA Univ, CHA Canc Res Ctr, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam 463707, Kyunggi Do, South Korea
[4] Choi Won Suk Urol Clin, Yongin, South Korea
[5] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA
[6] Chung Ang Univ, Coll Med, Adv Urogenital Dis Res Ctr, Seoul 156756, South Korea
[7] Chung Ang Univ, Coll Med, Res Inst Translat Syst Biom, Seoul 156756, South Korea
[8] Chung Ang Univ, Coll Med, Dept Urol, Seoul 156756, South Korea
基金
新加坡国家研究基金会;
关键词
prostate; CYP24A1; polymorphism; cancer risk; VITAMIN-D-RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; D PATHWAY; DISEQUILIBRIUM; DIAGNOSIS; ANDROGEN; VDR;
D O I
10.1038/pcan.2014.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Vitamin D-deactivating enzyme CYP24A1 had controversial effects on prostate cancer risk; the genetic study also showed the controversial results. Therefore, we identified the relationships between polymorphisms in CYP24A1 and prostate cancer in a Korean cohort. METHODS: We evaluated the association between 21 single-nucleotide polymorphisrns (SNPs) in the CYP24A1 and prostate cancer in Korean men (272 prostate cancers and 173 controls). BPH patients with high PSA or abnormal digital rectal examination who underwent negative prostate biopsy were enrolled in the control group. Twenty-one SNPs in the CYP24A1 were selected from the International HapMap database and the NCBI database with calculation of minor allele frequency and linkage disequilibrium, preferably including the SNPs that were nonsynonymous and located within exons. We also investigated the association between 21 SNPs in the CYP24A1 gene and known clinical characteristics, such as the PSA level, clinical stage, pathological stage and Gleason score. RESULTS: The statistical analysis suggested that five CYP24A1 sequence variants (rs2248461- odds ratio (OR): 0.63, rs2248359-OR: 0.65, rs6022999-OR: 0.65, rs2585428-OR: 0.46, rs4809959 -OR: 0.52) had a significant association with prostate cancer risk after multiple comparisons by a method of false discovery rate. Logistic analyses of the CYP24A1 polymorphisms with several prostate cancer-related factors showed that several SNPs were significant: four SNPs to PSA level, three to clinical stage, two to pathological stage and two SNPs to the Gleason score. CONCLUSIONS: The results of this study suggest that some CYP24A1 gene polymorphisms might be associated with the risk of prostate cancer in Korean men. Five CYP24A1 sequence variants showed the significance to predict prostate cancer, and several SNPs of CYP24A1 gene had an important finding to predict prostate cancer-related factors. However, these results should be validated in future large-scale studies.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 32 条
  • [1] Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk
    Ahn, Jiyoung
    Albanes, Demetrius
    Berndt, Sonja I.
    Peters, Ulrike
    Chatterjee, Nilanjan
    Freedman, Neal D.
    Abnet, Christian C.
    Huang, Wen-Yi
    Kibel, Adam S.
    Crawford, E. David
    Weinstein, Stephanie J.
    Chanock, Stephen J.
    Schatzkin, Arthur
    Hayes, Richard B.
    [J]. CARCINOGENESIS, 2009, 30 (05) : 769 - 776
  • [2] Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO
  • [3] 2-E
  • [4] Controlling the false discovery rate in behavior genetics research
    Benjamini, Y
    Drai, D
    Elmer, G
    Kafkafi, N
    Golani, I
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) : 279 - 284
  • [5] Single and Multigenic Analysis of the Association between Variants in 12 Steroid Hormone Metabolism Genes and Risk of Prostate Cancer
    Beuten, Joke
    Gelfond, Jonathan A. L.
    Franke, Jennifer L.
    Weldon, Korri S.
    Crandall, AnaLisa C.
    Johnson-Pais, Teresa L.
    Thompson, Ian M.
    Leach, Robin J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (06) : 1869 - 1880
  • [6] Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States)
    Chan, JM
    Holick, CN
    Leitzmann, MF
    Rimm, EB
    Willett, WC
    Stampfer, MJ
    Giovannucci, EL
    [J]. CANCER CAUSES & CONTROL, 2006, 17 (02) : 199 - 208
  • [7] Genetic Variants in the Vitamin D Receptor Are Associated with Advanced Prostate Cancer at Diagnosis: Findings from the Prostate Testing for Cancer and Treatment Study and a Systematic Review
    Chen, Lina
    Smith, George Davey
    Evans, David M.
    Cox, Angela
    Lawlor, Debbie A.
    Donovan, Jenny
    Yuan, Wei
    Day, Ian N. M.
    Martin, Richard M.
    Lane, Athene
    Rodriguez, Santi
    Davis, Michael
    Zuccolo, Luisa
    Collin, Simon M.
    Hamdy, Freddie
    Neal, David
    Lewis, Sarah J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 2874 - 2881
  • [8] Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
    Eeles, Rosalind A.
    Al Olama, Ali Amin
    Benlloch, Sara
    Saunders, Edward J.
    Leongamornlert, Daniel A.
    Tymrakiewicz, Malgorzata
    Ghoussaini, Maya
    Luccarini, Craig
    Dennis, Joe
    Jugurnauth-Little, Sarah
    Dadaev, Tokhir
    Neal, David E.
    Hamdy, Freddie C.
    Donovan, Jenny L.
    Muir, Ken
    Giles, Graham G.
    Severi, Gianluca
    Wiklund, Fredrik
    Gronberg, Henrik
    Haiman, Christopher A.
    Schumacher, Fredrick
    Henderson, Brian E.
    Le Marchand, Loic
    Lindstrom, Sara
    Kraft, Peter
    Hunter, David J.
    Gapstur, Susan
    Chanock, Stephen J.
    Berndt, Sonja I.
    Albanes, Demetrius
    Andriole, Gerald
    Schleutker, Johanna
    Weischer, Maren
    Canzian, Federico
    Riboli, Elio
    Key, Tim J.
    Travis, Ruth C.
    Campa, Daniele
    Ingles, Sue A.
    John, Esther M.
    Hayes, Richard B.
    Pharoah, Paul D. P.
    Pashayan, Nora
    Khaw, Kay-Tee
    Stanford, Janet L.
    Ostrander, Elaine A.
    Signorello, Lisa B.
    Thibodeau, Stephen N.
    Schaid, Dan
    Maier, Christiane
    [J]. NATURE GENETICS, 2013, 45 (04) : 385 - 391
  • [9] Vitamin D receptor genotype and the risk of bone fractures in women
    Feskanich, D
    Hunter, DJ
    Willett, WC
    Hankinson, SE
    Hollis, BW
    Hough, HL
    Kelsey, KT
    Colditz, GA
    [J]. EPIDEMIOLOGY, 1998, 9 (05) : 535 - 539
  • [10] Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population
    Harris, SS
    Soteriades, E
    Coolidge, JAS
    Mudgal, S
    Dawson-Hughes, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4125 - 4130